Affiliation
Tullamore General Hospital, Offaly, Ireland.Issue Date
2012-01-31T16:33:36ZMeSH
AdultAge of Onset
Antibodies, Monoclonal/administration & dosage/adverse effects
Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use
Combined Modality Therapy
Humans
Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy/nursing/*therapy
Middle Aged
Stem Cell Transplantation/adverse effects
Metadata
Show full item recordCitation
Br J Nurs. 2011 Sep 22-Oct 13;20(17):S30.Journal
British journal of nursing (Mark Allen Publishing)PubMed ID
22067537Language
engISSN
0966-0461 (Print)0966-0461 (Linking)
Collections
Related articles
- Monoclonal antibodies in chronic lymphocytic leukemia.
- Authors: Ferrajoli A, Faderl S, Keating MJ
- Issue date: 2006 Sep
- Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).
- Authors: Leupin N, Schuller JC, Solenthaler M, Heim D, Rovo A, Beretta K, Gregor M, Bargetzi MJ, Brauchli P, Himmelmann A, Hanselmann S, Zenhäusern R
- Issue date: 2010 Apr
- Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.
- Authors: Badoux XC, Keating MJ, Wang X, O'Brien SM, Ferrajoli A, Faderl S, Burger J, Koller C, Lerner S, Kantarjian H, Wierda WG
- Issue date: 2011 Aug 25
- [Chronic lymphocytic leukemia].
- Authors: Wendtner CM
- Issue date: 2012 Jun
- Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.
- Authors: Oscier D, Fegan C, Hillmen P, Illidge T, Johnson S, Maguire P, Matutes E, Milligan D, Guidelines Working Group of the UK CLL Forum. British Committee for Standards in Haematology
- Issue date: 2004 May